# EDGAR Filing Document

**Accession Number:** 0000919484
**File Stem:** 0001213900-26-021894
**Filing Date:** 2026-2
**Character Count:** 18823
**Document Hash:** 4d9fca22c323568cc7166d8d52ebe07b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-021894.hdr.sgml**: 20260227

**ACCESSION NUMBER**: 0001213900-26-021894

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260227

**DATE AS OF CHANGE**: 20260227

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zivo Bioscience, Inc.
- **CENTRAL INDEX KEY:** 0001101026
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 870699977
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-79359
- **FILM NUMBER:** 26702956

**BUSINESS ADDRESS:**
- **STREET 1:** 21 E. LONG LAKE ROAD
- **STREET 2:** SUITE 100
- **CITY:** BLOOMFIELD HILLS
- **STATE:** MI
- **ZIP:** 48304
- **BUSINESS PHONE:** (248) 452 9866

**MAIL ADDRESS:**
- **STREET 1:** 21 E. LONG LAKE ROAD
- **STREET 2:** SUITE 100
- **CITY:** BLOOMFIELD HILLS
- **STATE:** MI
- **ZIP:** 48304

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTH ENHANCEMENT PRODUCTS INC
- **DATE OF NAME CHANGE:** 20040202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WESTERN GLORY HOLE INC
- **DATE OF NAME CHANGE:** 19991215
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STROME MARK E
- **CENTRAL INDEX KEY:** 0000919484

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** 100 WILSHIRE BLVD
- **STREET 2:** 15TH FL
- **CITY:** SANTA MONICA
- **STATE:** CA
- **ZIP:** 90401

## Exhibit 99.1

**Exhibit 99.1**

**JOINT FILING AGREEMENT**

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, Mark E. Strome, Strome Group, Inc., Strome Investment Management, LP, Strome Mezzanine Fund, LP and Strome Mezzanine Fund II, LP agree to the joint filing on behalf of each of them a statement on Schedule 13D/A (including amendments thereto, if any) with respect to the shares of common stock of Zivo Bioscience, Inc., a Michigan corporation, and that this Agreement may be included as an Exhibit to such joint filing.

Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D/A and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of February 27, 2026.

---

| | |
|:---|:---|
| /s/ Mark E. Strome | /s/ Mark E. Strome |
| Mark E. Strome | Mark E. Strome |
| **Strome Group, Inc.** | **Strome Group, Inc.** |
| By: | /s/ Mark E. Strome |
| Name: | Mark E. Strome |
| Its: | President |
| **Strome Investment Management, LP** | **Strome Investment Management, LP** |
| By: | Strome Group, Inc. |
| Its: | General Partner |
| By: | /s/ Mark E. Strome |
| Name: | Mark E. Strome |
| Its: | President |
| **Strome Mezzanine Fund, LP** | **Strome Mezzanine Fund, LP** |
| By: | Strome Mezzanine Fund II, LP |
|  | the surviving entity of the merger between |
|  | Strome Mezzanine Fund, LP and Strome |
|  | Mezzanine Fund II, LP |
| By: | Strome Investment Management, LP |
| Its: | General Partner |
| By: | Strome Group, Inc. |
| Its: | General Partner |
| By: | /s/ Mark E. Strome |
| Name: | Mark E. Strome |
| Its: | President |
| **Strome Mezzanine Fund II, LP** | **Strome Mezzanine Fund II, LP** |
| By: | Strome Investment Management, LP |
| Its: | General Partner |
| By: | Strome Group, Inc. |
| Its: | General Partner |
| By: | /s/ Mark E. Strome |
| Name: | Mark E. Strome |
| Its: | President |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 9)**

**Zivo Bioscience**

*(Name of Issuer)*

**Common Stock, par value $.001 per share**

*(Title of Class of Securities)*

**98978N101**

*(CUSIP Number)*

**Strome Group, Inc.**<br>Attn: Mark E. Strome 14120 Ventura Blvd.<br>Suite C-525<br>Sherman Oaks CA 91423<br>3108509700

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/31/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **98978N101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Mark E. Strome** | Name of reporting person<br>**Mark E. Strome** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**194303.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**278639.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**194303.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**278639.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**472942.00** | Aggregate amount beneficially owned by each reporting person<br>**472942.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**12.10%** | Percent of class represented by amount in Row (11)<br>**12.10%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **98978N101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Strome Group, Inc.** | Name of reporting person<br>**Strome Group, Inc.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**278639.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**278639.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**278639.00** | Aggregate amount beneficially owned by each reporting person<br>**278639.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**7.13%** | Percent of class represented by amount in Row (11)<br>**7.13%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

| **CUSIP No.** | **98978N101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Strome Investment Management, LP** | Name of reporting person<br>**Strome Investment Management, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**278639.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**278639.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**278639.00** | Aggregate amount beneficially owned by each reporting person<br>**278639.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**7.13%** | Percent of class represented by amount in Row (11)<br>**7.13%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **98978N101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Strome Mezzanine Fund, LP** | Name of reporting person<br>**Strome Mezzanine Fund, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**0.00** | Aggregate amount beneficially owned by each reporting person<br>**0.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **98978N101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Strome Mezzanine Fund II, LP** | Name of reporting person<br>**Strome Mezzanine Fund II, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**266198.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**266198.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**266198.00** | Aggregate amount beneficially owned by each reporting person<br>**266198.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.81%** | Percent of class represented by amount in Row (11)<br>**6.81%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $.001 per share

**(b) Name of Issuer:**
Zivo Bioscience

**(c) Address of Issuer's Principal Executive Offices:**
21 E. Long Lake Road, Suite 100, Bloomfield Hills, MI, 48304

**Item 4. Purpose of Transaction**

On December 31, 2025, the Funds effected a merger, with SMF merging into SMFII and SMFII as the surviving entity, by filing a Certificate of Merger with the Delaware Secretary of State. As a result of the merger, 75,939 shares of Common Stock held by SMF immediately prior to the merger are now held by SMFII.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Mark E. Strome:
1. Aggregate number: 472,942
2. Aggregate percentage: 12.10%

Strome Group, Inc.:
1. Aggregate number: 278,639
2. Aggregate percentage: 7.13%

Manager:
1. Aggregate number: 278,639
2. Aggregate percentage: 7.13%

SMF:
1. Aggregate number: 0
2. Aggregate percentage: 0.00%

SMFII:
1. Aggregate number: 266,198
2. Aggregate percentage: 6.81%

The aggregate percentage reported herein and on pages 2-5 hereof are based on 3,888,595 shares of Common Stock outstanding as of November 9, 2025.

**(b)**
Mark E. Strome:
1. Sole voting power: 194,303
2. Shared voting power: 278,639
3. Sole dispositive power: 194,303
4. Shared dispositive power: 278,639

Strome Group, Inc.:
1. Sole voting power: 0
2. Shared voting power: 278,639
3. Sole dispositive power: 0
4. Shared dispositive power: 278,639

Manager:
1. Sole voting power: 0
2. Shared voting power: 278,639
3. Sole dispositive power: 0
4. Shared dispositive power: 278,639

SMF:
1. Sole voting power: 0
2. Shared voting power: 0
3. Sole dispositive power: 0
4. Shared dispositive power: 0

SMFII:
1. Sole voting power: 0
2. Shared voting power: 266,198
3. Sole dispositive power: 0
4. Shared dispositive power: 266,198

**(c)**
On February 12, 2026, SMFII entered into a Securities Purchase Agreement with the Issuer, pursuant to which SMFII acquired 20,000 shares of Common Stock for $9.77 per share and Common Stock purchase warrant for no additional consideration that is exercisable for 2,000 shares of Common Stock at $9.77 per share, subject to certain adjustments. The shares are included in the aggregate number and percentage of the shares of Common Stock outstanding beneficially owned by each Reporting Person reported in paragraph (b) above and on pages 2-5 hereof.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Except as described elsewhere in this statement, no Reporting Person is a party to any contract, arrangement, understanding or relationship with respect to any securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Mark E. Strome

**Signature:** /s/ Mark E. Strome

**Name/Title:** Mark E. Strome

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Strome Group, Inc.

**Signature:** /s/ Mark E. Strome

**Name/Title:** Mark E. Strome/President

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Strome Investment Management, LP

**Signature:** /s/ Mark E. Strome

**Name/Title:** Mark E. Strome/President of Strome Group, Inc., GP of Strome Investment Management, LP

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Strome Mezzanine Fund, LP

**Signature:** /s/ Mark E. Strome

**Name/Title:** Mark E. Strome/President of Strome Group, Inc., GP of Strome Investment Management, LP, GP of Strome Mezzanine Fund II, LP, surviving entity of merger

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Strome Mezzanine Fund II, LP

**Signature:** /s/ Mark E. Strome

**Name/Title:** Mark E. Strome/President of Strome Group, Inc., GP of Strome Investment Management, LP, GP of Strome Mezzanine Fund II, LP

**Date:** 02/27/2026